Midostaurin (Rydapt)

midostaurin · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Midostaurin (Rydapt), covering 2016-07-06 to 2016-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]